Globe Life Sinks 8% After Q3 Earnings Disappoint and Piper Sandler Cuts to Neutral

Globe Life reported third-quarter 2026 net income of $361 million, or $4.62 per share, a 2% decline from $4.73 per share a year earlier. Net operating income came in at $379 million, or $4.84 per share, up just 1% from $4.81 per share in the prior-year period. Premium growth and share buybacks provided partial offsets to the results, but rising medical claims weighed on margins and drew analyst scrutiny.

Piper Sandler responded by cutting its rating on Globe Life from Overweight to Neutral and setting a price target of $165, arguing the insurer can no longer be considered a predictable safe haven given the margin pressure from medical claims. The downgrade landed hard with investors: shares fell roughly 8% on Friday, crossed below their 200-day moving average of $159.22, and touched an intraday low of $154.09, leaving the stock down approximately 7.3% on the session. Globe Life underperformed peers across the insurance sector on the day.